BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 9735166)

  • 21. Effect of 3,4-di(OH)-cinnamate synthetic derivative on plasma and hepatic cholesterol level and antioxidant enzyme activities in high cholesterol-fed rats.
    Park EJ; Lee S; Jeong TS; Bok SH; Lee MK; Park YB; Choi MS
    J Biochem Mol Toxicol; 2004; 18(5):279-87. PubMed ID: 15549704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feeding status-related effects of 17 beta-estradiol on liver 3-hydroxy-3-methylglutaryl CoA reductase.
    Alonso MA; Fernandez de Quincoces A; Lacort M; Gandarias JM; Ochoa B
    Exp Clin Endocrinol; 1993; 101(3):123-30. PubMed ID: 8223979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
    Johnston TP; Palmer WK
    Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
    J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Mediterranean-style, low-glycemic-load diet reduces the expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in mononuclear cells and plasma insulin in women with metabolic syndrome.
    Jones JL; Park Y; Lee J; Lerman RH; Fernandez ML
    Nutr Res; 2011 Sep; 31(9):659-64. PubMed ID: 22024489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of the proliferation of the Madin-Darby canine kidney (MDCK) epithelial cell line by high-density lipoproteins and their induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.
    Gospodarowicz D; Cohen DC; Massoglia SL
    J Cell Physiol; 1983 Oct; 117(1):76-90. PubMed ID: 6352714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats.
    Xu G; Salen G; Lea M; Tint GS; Nguyen LB; Batta AK; Chen TS; Shefer S
    Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia.
    Pallottini V; Martini C; Cavallini G; Donati A; Bergamini E; Notarnicola M; Caruso MG; Trentalance A
    J Cell Biochem; 2006 Aug; 98(5):1044-53. PubMed ID: 16741953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15-substituted lanosterols: post-transcriptional suppressors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Anderson JA; Leonard DA; Cusack KP; Frye LL
    Arch Biochem Biophys; 1995 Jan; 316(1):190-6. PubMed ID: 7840615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver.
    Pallottini V; Montanari L; Cavallini G; Bergamini E; Gori Z; Trentalance A
    Mech Ageing Dev; 2004 Sep; 125(9):633-9. PubMed ID: 15491682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells.
    Messa C; Notarnicola M; Russo F; Cavallini A; Pallottini V; Trentalance A; Bifulco M; Laezza C; Gabriella Caruso M
    Scand J Gastroenterol; 2005 Dec; 40(12):1454-61. PubMed ID: 16293557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis.
    Trzaskos JM; Magolda RL; Favata MF; Fischer RT; Johnson PR; Chen HW; Ko SS; Leonard DA; Gaylor JL
    J Biol Chem; 1993 Oct; 268(30):22591-9. PubMed ID: 7693673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological feedback regulation of cholesterol biosynthesis: Role of translational control of hepatic HMG-CoA reductase and possible involvement of oxylanosterols.
    Ness GC
    Biochim Biophys Acta; 2015 May; 1851(5):667-73. PubMed ID: 25701719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC; Holland RC; Lopez D
    Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
    Ness GC; Zhao Z; Keller RK
    Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.